Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No changes to core content, pricing, stock, or time slots.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has updated its facility name and location details, specifically replacing 'Milano, Italy, 20133' with 'Milan, Italy, 20133', and has added 'cabozantinib' as a new term. Additionally, the revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference0.8%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.